Table of Content

1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION & SCOPE 26
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 26
1.2.2 MARKET SEGMENTATION 26
FIGURE 1 EPILEPSY MONITORING DEVICES MARKET SEGMENTATION 26
1.2.3 YEARS CONSIDERED FOR THE STUDY 27
1.3 CURRENCY 27
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 27
1.4 STAKEHOLDERS 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH APPROACH 29
2.2 RESEARCH METHODOLOGY DESIGN 29
FIGURE 2 EPILEPSY MONITORING DEVICES MARKET: RESEARCH DESIGN 29
2.2.1 SECONDARY RESEARCH 30
2.2.1.1 Key data from secondary sources 31
2.2.2 PRIMARY RESEARCH 32
FIGURE 3 PRIMARY SOURCES 32
2.2.2.1 Key data from primary sources 33
2.2.2.2 Insights from primary experts 33
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.3 MARKET SIZE ESTIMATION: EPILEPSY MONITORING DEVICES MARKET 35
FIGURE 6 MARKET SIZE ESTIMATION: EPILEPSY MONITORING DEVICES MARKET 35
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 36
FIGURE 8 COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION: EPILEPSY MONITORING DEVICES MARKET 36
FIGURE 9 COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION: EEG MARKET 37
FIGURE 10 TOP-DOWN APPROACH 38
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE EPILEPSY MONITORING DEVICES MARKET (2021–2026) 39
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 41
FIGURE 13 DATA TRIANGULATION METHODOLOGY 41
2.5 MARKET SHARE ESTIMATION 42
2.6 ASSUMPTIONS FOR THE STUDY 42
2.7 LIMITATIONS 43
2.7.1 METHODOLOGY-RELATED LIMITATIONS 43
2.7.2 SCOPE-RELATED LIMITATIONS 43
2.8 RISK ASSESSMENT 43
TABLE 2 RISK ASSESSMENT: EPILEPSY MONITORING DEVICES MARKET 43
3 EXECUTIVE SUMMARY 44
FIGURE 14 EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 44
FIGURE 15 EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 45
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE EPILEPSY MONITORING DEVICES MARKET 46
4 PREMIUM INSIGHTS 47
4.1 EPILEPSY MONITORING DEVICES MARKET OVERVIEW 47
FIGURE 17 INCREASING INCIDENCE AND PREVALENCE OF EPILEPSY AND GROWING PREFERENCE FOR AMBULATORY HEALTHCARE AND HEALTH WEARABLES TO DRIVE MARKET GROWTH 47
4.2 EPILEPSY MONITORING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 18 CHINA TO WITNESS THE HIGHEST GROWTH IN THE EPILEPSY MONITORING DEVICES MARKET DURING THE FORECAST PERIOD 48
4.3 NORTH AMERICA: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT AND COUNTRY (2020) 49
FIGURE 19 CONVENTIONAL DEVICES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN EPILEPSY MONITORING DEVICES MARKET IN 2020 49
4.4 REGIONAL MIX: EPILEPSY MONITORING DEVICES MARKET (2021–2026) 49
FIGURE 20 APAC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021–2026) 49
4.5 EPILEPSY MONITORING DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS 50
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING
THE FORECAST PERIOD 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
FIGURE 22 EPILEPSY MONITORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
5.2.1 DRIVERS 52
5.2.1.1 Increasing incidence and prevalence of epilepsy 52
FIGURE 23 US: RATE OF DEATH WITH EPILEPSY AS THE UNDERLYING CAUSE
(2009–2019) 52
5.2.1.2 Rising awareness of neurodegenerative disorders, including epilepsy 53
5.2.1.3 Growing preference for ambulatory healthcare and increasing use of wearables 53
5.2.1.4 Growing demand for continuous monitoring 54
5.2.2 RESTRAINTS 54
5.2.2.1 High cost of complex epilepsy monitoring procedures and devices 54
5.2.2.2 Unfavorable reimbursement policies 54
5.2.3 OPPORTUNITIES 55
5.2.3.1 Increasing demand for non-invasive and minimally invasive devices 55
5.2.3.2 Expanding therapeutic applications of epilepsy monitoring devices 55
5.2.3.3 High epilepsy incidence and growing healthcare markets in emerging economies 55
FIGURE 24 NUMBER OF EPILEPSY CASES IN SELECT COUNTRIES (2016) 56
FIGURE 25 GLOBAL ANNUAL HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING ECONOMIES (1995 VS. 2012 VS. 2022) 57
5.2.4 CHALLENGES 57
5.2.4.1 Shortage of trained professionals 57
5.2.4.2 Issues related to product approval and commercialization 58
5.3 IMPACT OF COVID-19 ON THE EPILEPSY MONITORING DEVICES MARKET 58
5.4 PORTER’S FIVE FORCES ANALYSIS 59
FIGURE 26 DEGREE OF COMPETITION IS HIGH IN THE EPILEPSY MONITORING DEVICES MARKET 59
TABLE 3 EPILEPSY MONITORING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 59
5.5 REGULATORY ANALYSIS 61
TABLE 4 KEY REGULATIONS & STANDARDS GOVERNING MEDICAL DEVICES 61
5.6 ECOSYSTEM ANALYSIS 62
FIGURE 27 ECOSYSTEM ANALYSIS: EPILEPSY MONITORING DEVICES MARKET 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS 63
FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2011–SEPTEMBER 2021) 63
5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 64
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR EPILEPSY MONITORING DEVICE PATENTS (JANUARY 2011–SEPTEMBER 2021) 64
FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR EPILEPSY MONITORING DEVICE PATENTS (JANUARY 2011–SEPTEMBER 2021) 65
6 EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT 66
6.1 INTRODUCTION 67
TABLE 5 EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 67
6.2 CONVENTIONAL DEVICES 67
TABLE 6 COMPANIES PROVIDING CONVENTIONAL EPILEPSY MONITORING DEVICES 68
TABLE 7 CONVENTIONAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 68
TABLE 8 CONVENTIONAL DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 69
6.2.1 MONITORING DEVICES 69
TABLE 9 MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 70
TABLE 10 MONITORING DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 70
6.2.1.1 EEG devices 70
TABLE 11 EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 71
TABLE 12 EEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 71
6.2.1.1.1 Standard EEG devices 72
6.2.1.1.1.1 Standard EEG devices accounted for the largest share of the EEG devices market 72
TABLE 13 COMPANIES PROVIDING STANDARD EEG DEVICES 72
TABLE 14 STANDARD EEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 72
6.2.1.1.2 Video EEG devices 73
6.2.1.1.2.1 Video EEG enables healthcare professionals to observe a patient during a seizure event and compare the visuals to the EEG results for better treatment planning 73
TABLE 15 COMPANIES PROVIDING VIDEO EEG DEVICES 73
TABLE 16 VIDEO EEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 74
6.2.1.1.3 Other/Ambulatory EEG devices 74
6.2.1.1.3.1 Ambulatory EEG is more cost-effective and convenient in comparison with routine EEG 74
TABLE 17 COMPANIES PROVIDING AMBULATORY EEG DEVICES 75
TABLE 18 OTHER/AMBULATORY EEG DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 75
6.2.1.2 EMG devices 76
6.2.1.2.1 High demand for EMG devices is mainly due to the increasing prevalence of neuromuscular diseases 76
TABLE 19 COMPANIES PROVIDING EMG DEVICES 76
TABLE 20 EMG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 77
6.2.1.3 MEG devices 77
6.2.1.3.1 MEG devices are more technologically advanced than other monitoring devices as they can simultaneously measure data from several points on the surface of the head 77
TABLE 21 COMPANIES PROVIDING MEG DEVICES 77
TABLE 22 MEG DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 78
6.2.1.4 Other monitoring devices 78
TABLE 23 COMPANIES PROVIDING OTHER MONITORING DEVICES 78
TABLE 24 OTHER MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 79
6.2.2 DEEP BRAIN STIMULATION DEVICES 79
6.2.2.1 Successful DBS allows people to potentially reduce their medications and improve their quality of life 79
TABLE 25 DEEP BRAIN STIMULATION DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 80
6.3 WEARABLE DEVICES 80
6.3.1 HIGH PREFERENCE FOR WEARABLE DEVICES DUE TO EASE OF USE IS A KEY FACTOR DRIVING MARKET GROWTH 80
TABLE 26 COMPANIES PROVIDING WEARABLE EPILEPSY MONITORING DEVICES 81
TABLE 27 WEARABLE DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 81
?
7 EPILEPSY MONITORING DEVICES MARKET, BY END USER 82
7.1 INTRODUCTION 83
TABLE 28 EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 83
7.2 HOSPITALS 84
7.2.1 HOSPITALS CAN INVEST IN EXPENSIVE AND SOPHISTICATED TECHNOLOGIES, OWING TO WHICH THE ADOPTION OF EPILEPSY MONITORING DEVICES IS HIGHER AMONG HOSPITALS 84
TABLE 29 EPILEPSY MONITORING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION) 84
7.3 NEUROLOGY CENTERS 85
7.3.1 HIGH PREFERENCE FOR THE DIAGNOSIS AND TREATMENT OF BRAIN DISORDERS AT NEUROLOGY CENTERS IS A MAJOR FACTOR DRIVING MARKET GROWTH 85
TABLE 30 EPILEPSY MONITORING DEVICES MARKET FOR NEUROLOGY CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION) 85
7.4 AMBULATORY SURGERY CENTERS & CLINICS 86
7.4.1 PATIENTS ARE INCREASINGLY OPTING FOR AMBULATORY SURGERY CENTERS & CLINICS AS A MORE CONVENIENT ALTERNATIVE TO HOSPITAL-BASED OUTPATIENT PROCEDURES 86
TABLE 31 EPILEPSY MONITORING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION) 86
7.5 DIAGNOSTIC CENTERS 87
7.5.1 DIAGNOSTIC CENTERS OFFER DIAGNOSIS AND TREATMENT OPTIONS FOR VARIOUS NEUROLOGICAL CONDITIONS?A KEY FACTOR DRIVING MARKET GROWTH 87
TABLE 32 EPILEPSY MONITORING DEVICES MARKET FOR DIAGNOSTIC CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION) 87
7.6 HOME CARE SETTINGS 88
7.6.1 GROWING NEED FOR LONG-TERM HOME CARE TO DRIVE MARKET GROWTH 88
TABLE 33 EPILEPSY MONITORING DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 88
8 EPILEPSY MONITORING DEVICES MARKET, BY REGION 89
8.1 INTRODUCTION 90
TABLE 34 EPILEPSY MONITORING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 90
8.2 NORTH AMERICA 91
FIGURE 31 NORTH AMERICA: EPILEPSY MONITORING DEVICES MARKET SNAPSHOT 91
TABLE 35 NORTH AMERICA: EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 92
TABLE 36 NORTH AMERICA: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 92
TABLE 37 NORTH AMERICA: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 92
TABLE 38 NORTH AMERICA: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 93
TABLE 39 NORTH AMERICA: EEG DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 93
TABLE 40 NORTH AMERICA: EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 93
8.2.1 US 94
8.2.1.1 The US dominates the North American epilepsy monitoring devices market 94
TABLE 41 US: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 94
TABLE 42 US: CONVENTIONAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 95
TABLE 43 US: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 95
TABLE 44 US: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 95
TABLE 45 US: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 96
8.2.2 CANADA 96
8.2.2.1 Growing number of hospitals and surgical centers to drive the demand for epilepsy monitoring devices in Canada 96
TABLE 46 CANADA: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 96
TABLE 47 CANADA: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 97
TABLE 48 CANADA: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 97
TABLE 49 CANADA: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 97
TABLE 50 CANADA: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 98
8.3 EUROPE 98
TABLE 51 EUROPE: EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
TABLE 52 EUROPE: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 99
TABLE 53 EUROPE: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 99
TABLE 54 EUROPE: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 55 EUROPE: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 100
TABLE 56 EUROPE: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 100
8.3.1 GERMANY 101
8.3.1.1 High burden of Alzheimer’s in the country will support market growth 101
TABLE 57 GERMANY: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 101
TABLE 58 GERMANY: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 101
TABLE 59 GERMANY: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 102
TABLE 60 GERMANY: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 102
TABLE 61 GERMANY: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 102
8.3.2 UK 103
8.3.2.1 Increasing investments by public and private sectors to drive
the growth of the epilepsy monitoring devices market in the UK 103
TABLE 62 UK: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 103
TABLE 63 UK: CONVENTIONAL DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 103
TABLE 64 UK: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 104
TABLE 65 UK: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 104
TABLE 66 UK: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 104
8.3.3 FRANCE 105
8.3.3.1 Increasing geriatric population to drive market growth in France 105
TABLE 67 FRANCE: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 105
TABLE 68 FRANCE: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 105
TABLE 69 FRANCE: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 106
TABLE 70 FRANCE: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
TABLE 71 FRANCE: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 106
8.3.4 REST OF EUROPE 107
TABLE 72 ROE: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 107
TABLE 73 ROE: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 74 ROE: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 108
TABLE 75 ROE: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 108
TABLE 76 ROE: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 108
8.4 ASIA PACIFIC 109
FIGURE 32 ASIA PACIFIC: EPILEPSY MONITORING DEVICES MARKET SNAPSHOT 109
TABLE 77 APAC: EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
TABLE 78 APAC: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 110
TABLE 79 APAC: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 110
TABLE 80 APAC: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 111
TABLE 81 APAC: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 111
TABLE 82 APAC: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 111
8.4.1 JAPAN 112
8.4.1.1 Incidence of epilepsy in Japan is expected to increase due to
the large geriatric population 112
TABLE 83 JAPAN: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 112
TABLE 84 JAPAN: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 85 JAPAN: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 113
TABLE 86 JAPAN: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 113
TABLE 87 JAPAN: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 113
8.4.2 CHINA 114
8.4.2.1 China to register the highest growth in the epilepsy monitoring devices market during the forecast period 114
TABLE 88 CHINA: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 114
TABLE 89 CHINA: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 114
TABLE 90 CHINA: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 91 CHINA: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 115
TABLE 92 CHINA: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 115
8.4.3 INDIA 116
8.4.3.1 Improving healthcare infrastructure in the country will support the growth of the epilepsy monitoring devices market 116
TABLE 93 INDIA: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 116
TABLE 94 INDIA: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 116
TABLE 95 INDIA: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 117
TABLE 96 INDIA: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 117
TABLE 97 INDIA: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 117
8.4.4 REST OF ASIA PACIFIC 118
TABLE 98 ROAPAC: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 118
TABLE 99 ROAPAC: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 118
TABLE 100 ROAPAC: MONITORING DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 119
TABLE 101 ROAPAC: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 119
TABLE 102 ROAPAC: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 119
8.5 REST OF THE WORLD 120
TABLE 103 ROW: EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 120
TABLE 104 ROW: CONVENTIONAL DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 105 ROW: MONITORING DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 106 ROW: EEG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 107 ROW: EPILEPSY MONITORING DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 121
9 COMPETITIVE LANDSCAPE 122
9.1 OVERVIEW 122
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 122
9.2.1 OVERVIEW OF THE STRATEGIES ADOPTED BY PLAYERS IN THE EPILEPSY MONITORING DEVICES MARKET 123
9.3 COMPETITIVE BENCHMARKING 124
TABLE 108 FOOTPRINT OF COMPANIES IN THE EPILEPSY MONITORING DEVICES MARKET 124
TABLE 109 COMPANY END-USER FOOTPRINT (25 COMPANIES) 125
TABLE 110 COMPANY REGIONAL FOOTPRINT (26 COMPANIES) 126
9.4 COMPETITIVE LEADERSHIP MAPPING 127
9.4.1 STARS 127
9.4.2 EMERGING LEADERS 128
9.4.3 PERVASIVE PLAYERS 128
9.4.4 PARTICIPANTS 128
FIGURE 33 EPILEPSY MONITORING DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2020) 129
9.5 COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES 130
9.5.1 PROGRESSIVE COMPANIES 130
9.5.2 DYNAMIC COMPANIES 130
9.5.3 STARTING BLOCKS 130
9.5.4 RESPONSIVE COMPANIES 130
FIGURE 34 EPILEPSY MONITORING DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES (2020) 131
9.6 MARKET SHARE ANALYSIS 132
FIGURE 35 EPILEPSY MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2020 132
TABLE 111 EPILEPSY MONITORING DEVICES MARKET: DEGREE OF COMPETITION 133
9.7 COMPETITIVE SCENARIO 134
TABLE 112 PRODUCT LAUNCHES & APPROVALS, 2018–2021 134
10 COMPANY PROFILES 136
10.1 KEY PLAYERS 136
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
10.1.1 NATUS MEDICAL, INC. 136
TABLE 114 NATUS MEDICAL, INC.: BUSINESS OVERVIEW 136
FIGURE 36 NATUS MEDICAL, INC.: COMPANY SNAPSHOT (2020) 137
10.1.2 COMPUMEDICS LIMITED 140
TABLE 115 COMPUMEDICS LIMITED: BUSINESS OVERVIEW 140
FIGURE 37 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2020) 140
10.1.3 NIHON KOHDEN CORPORATION 143
TABLE 116 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 143
FIGURE 38 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2020) 144
10.1.4 THE MAGSTIM CO. LTD. 146
TABLE 117 THE MAGSTIM CO. LTD.: BUSINESS OVERVIEW 146
10.1.5 MEDTRONIC PLC 148
TABLE 118 MEDTRONIC PLC: BUSINESS OVERVIEW 148
FIGURE 39 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 149
10.1.6 EMPATICA, INC. 151
TABLE 119 EMPATICA, INC.: BUSINESS OVERVIEW 151
10.1.7 MASIMO CORPORATION 153
TABLE 120 MASIMO CORPORATION: BUSINESS OVERVIEW 153
FIGURE 40 MASIMO CORPORATION: COMPANY SNAPSHOT (2020) 153
10.1.8 BOSTON SCIENTIFIC CORPORATION 155
TABLE 121 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 155
FIGURE 41 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 156
10.1.9 ABBOTT LABORATORIES, INC. 158
TABLE 122 ABBOTT LABORATORIES, INC.: BUSINESS OVERVIEW 158
FIGURE 42 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT (2020) 159
10.1.10 ALEVA NEUROTHERAPEUTICS S.A. 161
TABLE 123 ALEVA NEUROTHERAPEUTICS S.A.: BUSINESS OVERVIEW 161
10.1.11 DR?GERWERK AG & CO. KGAA 162
TABLE 124 DR?GERWERK AG & CO. KGAA: BUSINESS OVERVIEW 162
FIGURE 43 DR?GERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2020) 163
10.1.12 MEDPAGE LTD. 165
TABLE 125 MEDPAGE LTD.: BUSINESS OVERVIEW 165
10.1.13 LIVASSURED B.V. 166
TABLE 126 LIVASSURED B.V.: BUSINESS OVERVIEW 166
10.1.14 MJN NEUROSERVEIS, S.L. 167
TABLE 127 MJN NEUROSERVEIS, S.L.: BUSINESS OVERVIEW 167
10.1.15 BIOSERENITY 168
TABLE 128 BIOSERENITY: BUSINESS OVERVIEW 168
10.1.16 NEUROSOFT 170
TABLE 129 NEUROSOFT: BUSINESS OVERVIEW 170
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS 172
10.2.1 ADVANCED BRAIN MONITORING, INC. 172
TABLE 130 ADVANCED BRAIN MONITORING, INC.: BUSINESS OVERVIEW 172
10.2.2 LIFELINES NEURO COMPANY, LLC 173
10.2.3 MITSAR CO., LTD. 174
10.2.4 RIMED 174
10.2.5 EMOTIV 175
10.2.6 CGX (A COGNIONICS COMPANY) 175
10.2.7 MINDRAY MEDICAL INTERNATIONAL LIMITED 176
10.2.8 CADWELL INDUSTRIES, INC. 177
10.2.9 NEUROWAVE SYSTEMS, INC. 178
10.2.10 MC10, INC. 178
11 APPENDIX 179
11.1 INSIGHTS FROM INDUSTRY EXPERTS 179
11.2 DISCUSSION GUIDE 180
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 184
11.4 AVAILABLE CUSTOMIZATIONS 186
11.5 RELATED REPORTS 186
11.6 AUTHOR DETAILS 187